loadpatents
Patent applications and USPTO patent grants for Srirangam; Jayaram K..The latest application filed is for "polymorphic and amorphous forms of 2,5-dimethyl-2h-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((e)-2 pyridin-2-yl-vinyl)-1h-indazol-6-ylamino]-phen- yl}-amide".
Patent | Date |
---|---|
Metabolites of prinomastat and their synthesis Grant 7,022,846 - Ouellette , et al. April 4, 2 | 2006-04-04 |
Polymorphic and amorphous forms of 2,5-dimethyl-2H-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((E)-2 pyridin-2-YL-vinyl)-1H-indazol-6-ylamino]-phen- yl}-amide App 20050267158 - Ye, Qiang ;   et al. | 2005-12-01 |
Metabolites of prinomastat and their synthesis App 20040053922 - Ouellette, Michael A. ;   et al. | 2004-03-18 |
Dolastatin peptides Grant 6,323,315 - Pettit , et al. November 27, 2 | 2001-11-27 |
Elucidation and synthesis of selected pentapeptides Grant 5,780,588 - Pettit , et al. July 14, 1 | 1998-07-14 |
Human cancer inhibitory peptide amides Grant 5,665,860 - Pettit , et al. September 9, 1 | 1997-09-09 |
Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides Grant 5,663,149 - Pettit , et al. September 2, 1 | 1997-09-02 |
Cancer inhibitory peptides Grant 5,599,902 - Pettit , et al. February 4, 1 | 1997-02-04 |
Human cancer inhibitory peptide amides Grant 5,530,097 - Pettit , et al. June 25, 1 | 1996-06-25 |
Human cancer inhibitory pentapeptide amides and esters Grant 5,521,284 - Pettit , et al. May 28, 1 | 1996-05-28 |
Human cancer inhibitory pentapeptide methyl esters Grant 5,504,191 - Pettit , et al. April 2, 1 | 1996-04-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.